Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
Friday
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health
Healthcare Communications | Pharmaceutical Executive | Medical Executive | Tech PR | Scientific Executive
         
Latest Jobs
Exclusive vacancies may not be shown here, please contact Liam on +44 1494 818 027 or liam@zenopa.com for more information.
Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Liam Whelan
Senior Account Manager
liam@zenopa.com
+44 1494 818 027

Testimonials
Working as a hospital specialist contractor for Zenopa has been a very positive experience. My contract manager was great. I genuinely felt she was on my side wanting me to do well.
Sadie, 2011

Agilent Technologies names new members of Keysight board

9 April 2014 17:09 in Scientific Company News


Agilent Technologies names new members of Keysight boardAgilent Technologies has announced the appointment of Paul Clark and James Cullen to the board of directors of its new spinoff Keysight Technologies.

These director appointments are set to become effective concurrently with, or shortly before, the completion of the Keysight spinoff, which is currently targeted for early November 2014. Mr Clark is expected to become chairman of Keysight's board.

Both Mr Clark and Mr Cullen are currently members of the Agilent board and will continue to serve in this capacity until the spinoff occurs. They have extensive experience of managing large companies.

Ron Nersesian, Keysight's president and chief executive officer, said: "Both have been key members of the Agilent board and possess an excellent understanding of Keysight's business."

Agilent announced in September 2013 that it will be separating into two publicly traded companies, with its current portfolio of electronic measurement products to operate under the Keysight name.

Meanwhile, its existing life sciences, diagnostics and applied markets operations will continue to trade as Agilent.ADNFCR-8000103-ID-801711391-ADNFCR

Other news stories from 09/04/2014

Related news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Axonn News Agency



                    
© Copyright 2014 Zenopa Ltd